CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

CROSS COUNTRY HEALTHCARE INC

CCRN
$426M
Small Cap
NASDAQServices-Help Supply Services🇺🇸North AmericaBOCA RATON9.6K employees

Drugs in Pipeline

0

Phase 3 Programs

0

Upcoming Catalysts

1

Next Catalyst

Aug 5, 2026

7d

Market Overview

Stock performance and key metrics

CCRN News
Catalyst Timeline

1 upcoming, 1 past

EarningsNext

CCRN Earnings Report

Aug 5, 2026

EPS Est: $0.03 | FQ end 2026-06

How CCRN's past catalysts played out

earningsMay 2024-6%earningsNov 2023-14%earningsAug 2023-17%earningsFeb 2023-6%earningsAug 2022-16%earningsMay 2022-9%earningsNov 2021+20%earningsAug 2021+25%
Drug Pipeline

No drugs found in this phase.

Chronic Liver Disease

2 drugs in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

📑
Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
→
Catalyst Verdict

Full breakdown — the signals behind the verdict

Market-Implied Move
Regulatory Approvals

Frequently asked questions

When is CROSS COUNTRY HEALTHCARE INC's next FDA catalyst?→

CROSS COUNTRY HEALTHCARE INC's (CCRN) next tracked catalyst is a Earnings expected August 5, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track CCRN biotech catalysts?→

Add CCRN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CROSS COUNTRY HEALTHCARE INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply